Salsman, Jayme <br/><br/>
PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.  [electronic resource] 

 -  Scientific reports  03 2017 
 - 45038 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep45038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cobalt--pharmacology<br/>Fibroblasts--metabolism<br/>Gene Expression Regulation<br/>Gene Knockout Techniques<br/>Gene Silencing<br/>Genetic Loci<br/>Humans<br/>Hypoxia--genetics<br/>Neoplasms--genetics<br/>Promyelocytic Leukemia Protein--metabolism<br/>Protein Binding<br/>Protein Biosynthesis<br/>Radiation, Ionizing<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Transcription Factors--genetics<br/>Transcription, Genetic